MarketCap
Facebook
X
TelegramAnnual report 2025
added 03-10-2026
Exagen ROCE Ratio 2011-2026 | XGN
Annual ROCE Ratio Exagen
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -80.63 | -142.94 | -100.63 | -108.46 | -28.34 | -21.82 | -11.28 | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| -11.28 | -142.94 | -70.58 |
Quarterly ROCE Ratio Exagen
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -118.39 | -137.53 | -139.74 | -65.97 | -84.4 | -66.59 | -67.29 | -55.28 | -69.19 | -64.68 | -71.65 | -49.01 | -56.17 | -49.42 | -32.99 | -18.61 | -27.66 | -29.54 | -31.75 | -29.69 | -33.57 | -28.4 | -24.56 | -11.57 | -10.56 | -5.67 | -1.34 | 1.01 | 1.01 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 1.01 | -139.74 | -47.56 |
ROCE Ratio of other stocks in the Diagnostics research industry
| Issuer | ROCE Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
-89.9 | - | -6.23 % | $ 30.6 M |  Germany |
 |
Aspira Women's Health
AWH
|
114.15 | - | -6.19 % | $ 10.5 M |  USA |
 |
Agilent Technologies
A
|
25.0 | $ 115.39 | -1.31 % | $ 35.1 B | USA |
 |
Biocept
BIOC
|
-360.98 | - | -13.05 % | $ 7.29 M | USA |
 |
BioNano Genomics
BNGO
|
-75.05 | $ 1.16 | -1.69 % | $ 6.32 M | USA |
 |
Chembio Diagnostics
CEMI
|
-132.81 | - | 0.22 % | $ 16.8 M | USA |
 |
DermTech
DMTK
|
-181.44 | - | -11.32 % | $ 2.94 M | USA |
 |
CareDx, Inc
CDNA
|
-10.16 | $ 16.69 | -6.86 % | $ 889 M | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
-2.26 | - | - | $ 562 M |  Britain |
|
Akumin
AKU
|
58.25 | - | -17.87 % | $ 25.9 M |  Canada |
 |
Enzo Biochem
ENZ
|
-22.04 | - | -8.98 % | $ 14.8 K | USA |
 |
Burning Rock Biotech Limited
BNR
|
-41.81 | $ 16.25 | 0.06 % | $ 175 M |  China |
 |
Exact Sciences Corporation
EXAS
|
-8.59 | - | - | $ 19.8 B | USA |
 |
Co-Diagnostics
CODX
|
-236.6 | $ 4.4 | 101.83 % | $ 5.85 M | USA |
 |
Accelerate Diagnostics
AXDX
|
62.7 | - | -61.36 % | $ 2.46 M | USA |
 |
Castle Biosciences
CSTL
|
1.9 | $ 23.43 | -6.99 % | $ 651 M | USA |
 |
Global Cord Blood Corporation
CO
|
12.48 | - | - | $ 399 M | China |
 |
Fluidigm Corporation
FLDM
|
-18.87 | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
-347.69 | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
-15.41 | - | 0.12 % | $ 80.1 M | China |
 |
Charles River Laboratories International
CRL
|
0.8 | $ 175.55 | 0.27 % | $ 8.7 B | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
9.75 | - | - | $ 10.7 B | USA |
 |
Danaher Corporation
DHR
|
8.93 | $ 192.99 | -1.63 % | $ 138 B | USA |
 |
Heska Corporation
HSKA
|
-4.81 | - | - | $ 1.31 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
-219.45 | - | -20.0 % | $ 1.06 M | USA |
 |
Interpace Biosciences
IDXG
|
18.26 | $ 2.3 | 16.02 % | $ 10.2 M | USA |
 |
Illumina
ILMN
|
-35.1 | $ 123.67 | -3.38 % | $ 19.7 B | USA |
 |
Fulgent Genetics
FLGT
|
-6.52 | $ 15.02 | -5.12 % | $ 454 M | USA |
 |
Koninklijke Philips N.V.
PHG
|
6.33 | $ 28.13 | 0.29 % | $ 20 B |  Niderland |
 |
Guardant Health
GH
|
440.3 | $ 87.17 | -6.11 % | $ 10.9 B | USA |
 |
QIAGEN N.V.
QGEN
|
8.07 | - | - | $ 10.6 B | Niderland |
 |
Anixa Biosciences
ANIX
|
-77.18 | $ 2.74 | 0.37 % | $ 88.9 K | USA |
 |
Biomerica
BMRA
|
-125.14 | $ 2.2 | 2.33 % | $ 5.05 M | USA |
 |
ICON Public Limited Company
ICLR
|
4.69 | $ 106.7 | 0.15 % | $ 8.8 B |  Irlanda |
 |
Check-Cap Ltd.
CHEK
|
1809.55 | - | - | $ 9.42 M |  Israel |
 |
Laboratory Corporation of America Holdings
LH
|
16.06 | $ 273.26 | -0.53 % | $ 22.7 B | USA |
 |
Celcuity
CELC
|
-171.24 | $ 124.64 | 6.58 % | $ 5.83 B | USA |
 |
Medpace Holdings
MEDP
|
116.53 | $ 501.5 | -3.68 % | $ 14.5 B | USA |
 |
Lantheus Holdings
LNTH
|
28.52 | $ 81.43 | 1.75 % | $ 5.5 B | USA |
 |
Motus GI Holdings
MOTS
|
-443.13 | - | -34.28 % | $ 263 K | Israel |
 |
Myriad Genetics
MYGN
|
-105.22 | $ 4.44 | -6.92 % | $ 411 M | USA |
 |
Quest Diagnostics Incorporated
DGX
|
21.7 | $ 197.82 | -0.5 % | $ 22 B | USA |
 |
NeoGenomics
NEO
|
-9.11 | $ 7.94 | -3.38 % | $ 1.02 B | USA |
 |
Neogen Corporation
NEOG
|
-51.22 | $ 10.04 | -2.95 % | $ 2.18 B | USA |
 |
ENDRA Life Sciences
NDRA
|
-185.74 | $ 5.31 | 2.71 % | $ 4.18 M | USA |
 |
National Research Corporation
NRC
|
161.47 | $ 17.05 | -1.22 % | $ 382 M | USA |
 |
Natera
NTRA
|
-76.66 | $ 203.0 | -3.71 % | $ 20 B | USA |
 |
Invitae Corporation
NVTA
|
-93.18 | - | - | $ 21.2 M | USA |
 |
Organovo Holdings
ONVO
|
-120.24 | - | -2.3 % | $ 19.4 M | USA |
 |
OpGen
OPGN
|
4.4 | - | -16.95 % | $ 1.54 M | USA |